Fortress Biotech Stock Fundamentals
| FBIO Stock | USD 1.97 0.01 0.51% |
Fortress Biotech fundamentals help investors to digest information that contributes to Fortress Biotech's financial success or failures. It also enables traders to predict the movement of Fortress Stock. The fundamental analysis module provides a way to measure Fortress Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fortress Biotech stock.
Fortress |
Fortress Biotech Company Profit Margin Analysis
Fortress Biotech's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Fortress Biotech Profit Margin | (0.64) % |
Most of Fortress Biotech's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fortress Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Fortress Biotech has a Profit Margin of -0.6405%. This is 94.29% lower than that of the Biotechnology sector and 97.22% lower than that of the Health Care industry. The profit margin for all United States stocks is 49.57% lower than that of the firm.
Fortress Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fortress Biotech's current stock value. Our valuation model uses many indicators to compare Fortress Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fortress Biotech competition to find correlations between indicators driving Fortress Biotech's intrinsic value. More Info.Fortress Biotech is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fortress Biotech's earnings, one of the primary drivers of an investment's value.Fortress Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fortress Biotech's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fortress Biotech could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics of similar companies.Fortress Biotech is currently under evaluation in profit margin category among its peers.
Fortress Fundamentals
| Return On Equity | -17.4 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (0.64) % | ||||
| Operating Margin | (2.81) % | ||||
| Current Valuation | 13.78 M | ||||
| Shares Outstanding | 19.92 M | ||||
| Shares Owned By Insiders | 25.41 % | ||||
| Shares Owned By Institutions | 15.25 % | ||||
| Number Of Shares Shorted | 1.67 M | ||||
| Price To Earning | (2.92) X | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 84.51 M | ||||
| Gross Profit | (85.66 M) | ||||
| EBITDA | (131.17 M) | ||||
| Net Income | (60.64 M) | ||||
| Cash And Equivalents | 208.35 M | ||||
| Cash Per Share | 1.92 X | ||||
| Total Debt | 88.59 M | ||||
| Debt To Equity | 1.24 % | ||||
| Current Ratio | 2.43 X | ||||
| Book Value Per Share | 1.19 X | ||||
| Cash Flow From Operations | (128.22 M) | ||||
| Short Ratio | 10.10 X | ||||
| Earnings Per Share | (6.03) X | ||||
| Price To Earnings To Growth | (0.10) X | ||||
| Target Price | 24.75 | ||||
| Number Of Employees | 186 | ||||
| Beta | 1.67 | ||||
| Market Capitalization | 36.25 M | ||||
| Total Asset | 167.53 M | ||||
| Retained Earnings | (694.87 M) | ||||
| Working Capital | 32.11 M | ||||
| Current Asset | 99.94 M | ||||
| Current Liabilities | 10.58 M | ||||
| Net Asset | 167.53 M |
About Fortress Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fortress Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fortress Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fortress Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Fortress Stock
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:Check out Fortress Biotech Piotroski F Score and Fortress Biotech Altman Z Score analysis. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.